Drug utilization pattern during pregnancy in North India

Indian Journal of Medical Sciences

Volumn 60, Issue 7, 2006, Pages 277-287

  Sharma, Rashmi ^a,b   Kapoor, Bhuvneshvar ^a   Verma, Ujala ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

(Pregnancy or prenatal care standards); Prescriptions, drug utilization, drug statistics and numerical data or drug utilization trends or drug utilization statistics and numerical data or drug utilization review methods

Indexed keywords

ANTACID AGENT; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIPROTOZOAL AGENT; AYURVEDIC DRUG; CALCIUM; CEPHALOSPORIN DERIVATIVE; CONTRACEPTIVE AGENT; DICLOFENAC; FOLIC ACID; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HOMEOPATHIC AGENT; IBUPROFEN; INSULIN; IRON; ISOXSUPRINE; LAXATIVE; METHYLDOPA; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOBARBITAL; PROGESTERONE; PROTON PUMP INHIBITOR; SEDATIVE AGENT; THYROXINE; UNINDEXED DRUG;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CHI SQUARE TEST; DRUG CLASSIFICATION; DRUG UTILIZATION; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH EDUCATION; HUMAN; INDIA; MEDICAL STUDENT; PREGNANCY; PRENATAL CARE; PRIMIGRAVIDA; QUESTIONNAIRE; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SELF MEDICATION; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

EID: 33746714368     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.26602     Document Type: Article

References (28)

1. Banhidy F, Lowry RB, Czeizel AE. Risk and Benefit of Drug Use During Pregnancy. Int J Med Sci 2005;2:100-6.
2. Sharma R, Verma U, Sharma CL, Kapoor B. Self-medication among urban population of Jammu city. Indian J Pharmacol 2005;37:37-45.
3. Carmo TA, Nitrini SM. Drug prescription for pregnant women: A pharmacoepidemiological study. Cad Saude Publica 2004;20:1004-13.
4. Drugs in Pregnancy and Lactation, 5th ed. Wilkins and Wilkin: Baltimore; 1998.
5. Nielsen GL, Norgaard B, Puho E, Rothman KJ, Sørensen HT, Czeize AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med 2005;22:693-6.
6. Czeizel AE, Toth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology 1999;10:437-40.
7. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
8. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br J Med 1993;306:1645-8.
9. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-83.
10. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Br Defect Res (Part A) 2004;70:853-61.
11. Heikkila AM, Erkkola RU, Nummi SE. Use of medication during pregnancy- A prospective cohort study on use and policy of prescribing. Ann Chir Gynaecol Suppl 1994;208:80-3.
12. Maats FH, Crowther CA. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Aust N Z J Obstet Gynaecol 2002;42:494-6.
13. Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness. Compl Ther Clin Pract 2006;12:27-33.
14. Scholl TO, Johnson WG. olic acid:influence on the outcome of pregnancy. Am J Clin Nutr 2000;71:1295S-303.
15. Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol 2002;156:806-12.
16. Nordeng H, Havnen GC. Impact of sociodemographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand 2005;84:26-33.
17. During Your Pregnancy: Is It Safe to Take Herbal Supplements. www.marchofdimes.com/pnhec/159_529.asp - 90k - assessed on 27.03.2006.
18. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
19. Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, De Jong-Van Den Berg LT. Drug prescription pattern before, during and after pregnancy for chronic, occasional and pregnancy related drugs in the Netherlands. Br J Obstet Gynecol 2006;113:559-68.
20. Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M, et al. Correlates of prescription drug use during pregnancy. Womens Health (Larchmt) 2005;14:401-9.
21. Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription of hazardous drugs during pregnancy. Drug Saf 2004;27:899-908.
22. Beyens MN, Guy C, Ratrema M, Ollagnier M. Prescription of drugs to pregnant women in france: The HIMAGE study. Therapie 2003;58:505-11.
23. Tisonova J, Magulova L, Goboova M, Wawruch M, Lassanova M, Bozekova L, et al. Consultation activity of two Slovak centres for pharmacotherapy during pregnancy and lactation. Cas Lek Cesk 2006;145:154-9.
24. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188:1039-45.
25. Drhova L. Knowledge, attitudes and behaviour of the population of the Czech Republic to self-medication-II. Knowledge of and information about drugs. Ceska Slov Farm 2005;54:168-72.
26. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. Br Med J 2003;327:68.
27. Takkar N, Goel P, Saha PK, Dua D. Contraceptive practices and awareness of emergency contraception in educated working women. Indian J Med Sci 2005;59:143-9.
28. Tamblyn R, Abrahamowicz M, Dauphinee D, Girard N, Bartlett G, Grand'Maison P, et al. Effect of a community oriented problem based learning curriculum on quality of primary care delivery by graduates: Historical cohort comparison. Br Med J 2005;331:1001-5.